Protein engineering is the process of altering the structure and function of proteins to create molecules with desired properties. This is usually accomplished by introducing mutations at specific sites in the protein or by using recombinant DNA technology to insert foreign genetic material into the protein's DNA. The goal of protein engineering is to create proteins with improved characteristics, such as increased stability, activity, or specificity.

SeSaM-Biotech is dedicated to first-class Directed Enzyme Evolution, also known as Protein Engineering. Our labs located in Aachen, germany fulfill the modern standards and are endowed with every necessary equipment for high quality projects. With the excellent RWTH aachen university nearby, sesam-biotech is at the very right spot to conduct its innovative research .

Protein Technologies Ltd. (PTL) is an award-winning, biotech company established in 2010. The company provides contract research services to the biotech industry.

Since its conception it has received multiple awards and funding from the UK government’s Technology Strategy Board (now Innovate UK), Bill and Melinda Gates Foundation and The Wellcome Trust for its innovation in biotechnology.

PTL is a world-leading innovator in the fields of recombinant proteins, protein engineering, biotherapeutics, biosensors, and bioreactors. PTL operates from state-of-the-art laboratories at Manchester Science Park in the United Kingdom.

Magellan Life Sciences develops proprietary protein engineering and expression platforms. These platforms are used to develop novel proteins for the food, health and nutrition sector.

The National institutes of health awarded Protabit a Phase II SBIR grant to continue development of their protein engineering database. The database will provide a central repository for all types of protein engineering data spanning a wide range of protein properties. It will provide an industry-wide standard format for reporting mutant protein sequences and experimental assay data that will facilitate comparison of results across different data sets .

Navigo Proteins develops precision affinity ligands based on selected protein scaffolds. Our outstanding protein engineering capabilities rely on our dedicated specialist team with in-depth expertise and a strong track record. With our highly experienced specialist team and our continuously evolving technology platform we combine our expertise with that of our partners to optimize biologics manufacturing .

RemeGen biosciences focuses on the discovery and development of innovative medicines for the treatment of cancer and autoimmune diseases. We leverage our deep insights into human biology, advanced protein engineering and design technologies .

Forbius is a protein engineering company that designs and develops biotherapeutics for the treatment of diseases with unmet need. Our strength is designing highly active inhibitors of validated biological pathways. We have a unique approach to designing traps that results in superior potency compared to traditional trap engineering approaches.

Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions. Technical storage or access is strictly necessary for the legitimate purpose of enabling a specific service explicitly requested by the subscriber or user .

Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The Inhibrx pipeline is focused on oncology, orphan diseases and infectious diseases. Inhibrx has collaborations with Celgene and bluebird bio and has received awards from several granting agencies, including NIH, NIAID and CARB-X.

Structured Immunity is a protein engineering company determined to improve the safety of T cell based therapies by increasing the target specificity of T cell receptors. 
 Structured Immunity’s mission is to improve the safety and effectiveness of T cell receptor based therapies. The technology behind Structured Immunity stems from over 20 years of research within the laboratory of Brian Baker.  David Hardwicke and Timothy Riley thus founded Structured Immunity in 2017 to provide global expertise in structural immunology and the most advanced structure based TCR optimization platform available today.



Protein Engineering

What is Protein Engineering?

Similar technologies

SeSaM-Biotech GmbH

Protein Technologies

Magellan Life Sciences

Protabit

Navigo Proteins GmbH

RemeGen Biosciences

Forbius

PEACCEL

Inhibrx

Structured Immunity